Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes.

European journal of gastroenterology & hepatology - 1 Feb 2006

Robaeys Geert, Van Vlierberghe Hans, Matheï Catharina, Van Ranst Marc, Bruckers Liesbeth, Buntinx Frank

Abstract excerpt

OBJECTIVES: There is some reluctance to treat intravenous drug users (IVDUs) with chronic hepatitis C (CHC) because of presumed lower compliance and response to antiviral therapy. We intended to evaluate the compliance and response to antiviral treatment for CHC in IVDUs compared with non-IVDUs. METHODS: A retrospective cohort study--secondary analysis of the results of a treatment trial--was performed in Belgium...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Administration Schedule
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Patient Compliance

Share to Ribavirin

Share to Substance Abuse, Intravenous

Share to Viral Load

Source

Identifiers

PMID: 16394797
DOI: 10.1097/00042737-200602000-00008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes.PMID 16394797Read ↗

Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.Semantic proximity Read ↗

Characteristics of chronic hepatitis C among intravenous drug users: a comparative analysis.Semantic proximity Read ↗

Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.Semantic proximity Read ↗

[Treatment of hepatitis C in intravenous drug users].Semantic proximity Read ↗

The success of treatment of chronic hepatitis C in opiate addicts in Clinical Center of Vojvodina.Semantic proximity Read ↗

Management of hepatitis C virus (HCV) infection in drug substitution programs.Semantic proximity Read ↗

Subtype distribution among intravenous drug users with chronic type C hepatitis in southern Spain.Semantic proximity Read ↗

Should active injecting drug users receive treatment for chronic hepatitis C?Semantic proximity Read ↗

[Distribution of Hepatitis C Virus (HCV) Genotypes Among Intravenous Drug and Non-Drug User Patients].Semantic proximity Read ↗

Hepatitis C viral clearance in an intravenous drug-using cohort in the Dublin area.Semantic proximity Read ↗

Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users.Semantic proximity Read ↗

Comparison of effectiveness and discontinuation of interferon-free therapy for hepatitis C in prison inmates and noninmates.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.